

Fundamental dimension Equity attribute | MALeader $623.60▼-1.52% Cap $546.3BP/E 34.2x QuantScore61/100 | AXPPeer $313.03▼-3.73% Cap $211.4BP/E 17.6x QuantScore55/100 | EVTCPeer $32.43▼-2.70% Cap $2.00BP/E 21.1x QuantScore58/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
83/100 |
57/100 |
85/100 |
Valuation Multiples, PEG & DCF upside | 51/100 | 77/100 | 95/100 |
Health Piotroski, Altman Z, leverage & liquidity | 56/100 | 60/100 | 21/100 |
Growth Revenue / earnings growth & margins | 57/100 | 40/100 | 49/100 |
Sentiment Analyst ratings, targets & revisions | 57/100 | 39/100 | 41/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 34.2x | 17.6x | 21.1x |
Forward P/E (next FY) | 31.2x | 17.8x | 8.1x |
EV / EBITDA (TTM) | 25.2x | 8.5x | 8.5x |
Price / Sales | 15.6x | 2.5x | 2.0x |
Price / Free Cash Flow | 34.2x | 14.4x | 10.5x |
PEG ratio | 1.51 | 0.89 | -0.73 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 8 / 9 | 5 / 9 |
Altman Z-Score | 10.34 (Safe) | 1.32 (Distress) | 1.85 (Grey) |
Total debt / equity | 4.39 | 0.19 | 2.06 |
Quick ratio | 1.1x | 34.1x | 1.7x |
Interest coverage | 27.6x | 3.0x | 2.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +16.4% | +8.4% | +10.2% |
Net income growth YoY | +16.3% | +7.0% | +25.7% |
Gross margin (TTM) | 100.0% | 85.2% | 43.4% |
Operating margin (FY) | 57.6% | 17.1% | 20.0% |
FCF margin (FY) | 50.1% | 19.9% | 14.5% |
5. Trailing price performancePrice change over period |
1M return | +10.2% | +3.7% | +15.0% |
3M return | +15.6% | -8.2% | +9.1% |
6M return | +23.7% | -1.7% | +9.9% |
Year to date | +9.2% | -15.4% | +11.5% |
1Y return | +8.7% | -11.8% | +4.5% |
3Y return | +61.2% | +116.5% | -8.3% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $512.11 -17.9% premium | $203.77 -34.9% premium | $102.69 +216.6% upside |
Wall Street consensus target | $675.40 +8.3% · range $597.00–$740.00 | $360.50 +15.2% · range $315.00–$400.00 | $34.00 +4.8% · range $34.00–$34.00 |
Consensus stance | 80% Buy20% Hold0% Sell | 40% Buy53% Hold7% Sell | 61% Buy39% Hold-0% Sell |